S Loukides

Author PubWeight™ 23.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005 5.24
2 Exhaled nitric oxide in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 1.60
3 Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. Eur J Clin Invest 2006 1.04
4 Exhalation flow and pressure-controlled reservoir collection of exhaled nitric oxide for remote and delayed analysis. Thorax 1998 1.04
5 Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy 2008 1.01
6 Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress. Thorax 1998 0.99
7 Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia. Thorax 2003 0.95
8 Total nitrite/nitrate in expired breath condensate of patients with asthma. Respir Med 2001 0.94
9 Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999 0.93
10 Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial. Ann Oncol 2004 0.90
11 The prevalence of congenital bronchial atresia in males. Monaldi Arch Chest Dis 2004 0.86
12 Evaluation of nasal patency: comparison of patient and clinician assessments with rhinomanometry. Acta Otolaryngol 1998 0.83
13 Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma. Allergy 2012 0.83
14 Effect of arginine on mucociliary function in primary ciliary dyskinesia. Lancet 1998 0.82
15 Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients. PLoS One 2012 0.81
16 Leukotriene E(4) in urine in patients with asthma and COPD--the effect of smoking habit. Respir Med 2006 0.80
17 Magnesium levels in plasma and erythrocytes before and after histamine challenge. Eur Respir J 2000 0.79
18 Prostaglandin E2 in the expired breath condensate of patients with asthma. Eur Respir J 2003 0.77
19 Sputum interleukin-13 as a biomarker for the evaluation of asthma control. Clin Exp Allergy 2016 0.76
20 Levels of prostaglandin E(2) and Cysteinyl-leukotrienes in sputum supernatant of patients with asthma: the effect of smoking. Clin Exp Allergy 2013 0.75
21 Bilateral pleural effusions associated with pravastatin sodium treatment. Eur Respir J 2007 0.75
22 The usefulness of inflammatory markers in monitoring treatment responses in asthma. Clin Exp Allergy 2003 0.75
23 Exhaled nitric oxide as screening tool in subjects with suspected asthma without reversibility. Int Arch Allergy Immunol 2013 0.75
24 Simultaneous pulmonary and intrathoracic lymph nodal granulomatosis of unknown significance (GLUS). Monaldi Arch Chest Dis 2004 0.75
25 Cytokine production by monocytes/macrophages is normal in patients with alveolar proteinosis: a report of two cases. Respiration 2001 0.75
26 Suppressive BALF lymphocyte phenotype in a patient with prolonged stable alveolar proteinosis. Respiration 1998 0.75